Concepedia

Shih‐Feng Cho

SC

34

Publications

1.1K

Citations

19

H-Index

2012

Active since

Affiliations

Kaohsiung Medical University(Current)

Kaohsiung Medical University Chung-Ho Memorial Hospital

Dana-Farber Cancer Institute

Tianjin University of Science and Technology

China Medical University

Shih‐Feng Cho is an author at Kaohsiung Medical University specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2012–2022

34

Publications

34

MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression

Shih‐Feng Cho, Yu-Li Chang, Chao‐Sung Chang et al. · BMC Cancer · 2014 · 149 citations · Full text

Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma

Liang Lin, Shih‐Feng Cho, Lijie Xing et al. · Leukemia · 2020 · 85 citations · Full text

, , +13

APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications

Yu‐Tzu Tai, Liang Lin, Lijie Xing et al. · Leukemia · 2018 · 83 citations

, , +9

The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models

Shih‐Feng Cho, Liang Lin, Lijie Xing et al. · Blood Advances · 2020 · 69 citations · Full text

A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma

Lijie Xing, Liang Lin, Tengteng Yu et al. · Leukemia · 2020 · 60 citations · Full text

, , +8

Rows per page

1–5 of 34